| 2020-08-06 | BOBO DONALD E JR | CVP,Strategy/Corp Development | Sell | 12,000 | $77.28 | $927,378.00 | -9.7% | → |
| 2020-08-06 | Ullem Scott B. | CVP, Chief Financial Officer | Sale+OE | 26,700 | $77.31 | $2,064,088.89 | -49.6% | → |
| 2020-08-03 | Wood Larry L | CVP, TAVR | Sale+OE | 10,698 | $78.40 | $838,716.78 | -2.9% | → |
| 2020-07-14 | Szyman Catherine M. | CVP, Critical Care | Sell | 2,249 | $67.66 | $152,167.34 | -7.2% | → |
| 2020-07-10 | WANG HUIMIN | CVP, Japan & Intercontinental | Sale+OE | 11,649 | $67.46 | $785,822.30 | -5.6% | → |
| 2020-07-10 | BOBO DONALD E JR | CVP,Strategy/Corp Development | Sale+OE | 13,074 | $67.46 | $882,031.86 | -7.7% | → |
| 2020-07-09 | MUSSALLEM MICHAEL A | Chairman & CEO | Sale+OE | 68,550 | $68.22 | $4,676,471.29 | -11.6% | → |
| 2020-07-06 | WANG HUIMIN | CVP, Japan & Intercontinental | Sell | 591 | $70.00 | $41,370.00 | -0.6% | → |
| 2020-07-06 | Ullem Scott B. | CVP, Chief Financial Officer | Sale+OE | 26,700 | $69.98 | $1,868,388.57 | -49.6% | → |
| 2020-07-01 | Wood Larry L | CVP, TAVR | Sale+OE | 10,698 | $68.90 | $737,112.84 | -1.4% | → |
| 2020-06-22 | Ullem Scott B. | CVP, Chief Financial Officer | Sale+OE | 26,700 | $69.51 | $1,855,928.50 | -25.3% | → |
| 2020-06-16 | Szyman Catherine M. | CVP, Critical Care | Sell | 3,348 | $70.67 | $236,603.16 | -9.7% | → |
| 2020-06-15 | MUSSALLEM MICHAEL A | Chairman & CEO | Sale+OE | 68,550 | $68.28 | $4,680,286.42 | -5.7% | → |
| 2020-06-12 | BOBO DONALD E JR | CVP,Strategy/Corp Development | Sale+OE | 13,074 | $69.86 | $913,313.03 | -15.2% | → |
| 2020-06-11 | WANG HUIMIN | CVP, Japan & Intercontinental | Sale+OE | 11,733 | $71.59 | $839,943.47 | -3.7% | → |
| 2020-06-11 | Szyman Catherine M. | CVP, Critical Care | Sell | 2,249 | $72.59 | $163,254.91 | -6.1% | → |
| 2020-06-01 | Wood Larry L | CVP, TAVR | Sale+OE | 10,698 | $75.30 | $805,559.40 | -2.9% | → |
| 2020-05-18 | WANG HUIMIN | CVP, Japan & Intercontinental | Sell | 1,717 | $216.68 | $372,039.56 | -5.2% | → |
| 2020-05-15 | BOBO DONALD E JR | CVP,Strategy/Corp Development | Sale+OE | 4,358 | $215.16 | $937,667.28 | -15.2% | → |
| 2020-05-14 | Szyman Catherine M. | CVP, Critical Care | Sell | 1,116 | $212.69 | $237,362.04 | -8.3% | → |
| 2020-05-13 | Szyman Catherine M. | CVP, Critical Care | Sale+OE | 750 | $216.93 | $162,697.50 | -5.3% | → |
| 2020-05-11 | WANG HUIMIN | CVP, Japan & Intercontinental | Sale+OE | 3,883 | $219.03 | $850,495.09 | -2.2% | → |
| 2020-05-08 | BOBO DONALD E JR | CVP,Strategy/Corp Development | Sale+OE | 5,372 | $220.94 | $1,186,889.68 | -19.3% | → |
| 2020-05-08 | MUSSALLEM MICHAEL A | Chairman & CEO | Sale+OE | 22,850 | $219.58 | $5,017,352.68 | -6.4% | → |
| 2020-05-01 | Wood Larry L | CVP, TAVR | Sale+OE | 3,566 | $215.00 | $766,690.00 | -2.9% | → |
| 2020-04-27 | Lemercier Jean-Luc M | CVP, EMEA, Canada, Latin Amer | Sale+OE | 3,470 | $223.50 | $775,545.00 | -7.6% | → |
| 2020-04-16 | Szyman Catherine M. | CVP, Critical Care | Sell | 1,116 | $216.91 | $242,071.56 | -7.0% | → |
| 2020-04-13 | WANG HUIMIN | CVP, Japan & Intercontinental | Sale+OE | 3,911 | $212.99 | $833,003.89 | -11.1% | → |
| 2020-04-07 | MUSSALLEM MICHAEL A | Chairman & CEO | Sale+OE | 2,315 | $199.54 | $461,941.65 | -0.8% | → |